Lv5
1270 积分 2024-01-19 加入
Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis
19天前
已关闭
Phase I/II Study of Treatment of Stage IV Breast Cancer with OKT3 x Trastuzumab–Armed Activated T Cells
3个月前
已完结
Simultaneous Activation of T Cells and Accessory Cells by a New Class of Intact Bispecific Antibody Results in Efficient Tumor Cell Killing
3个月前
已完结
B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges
5个月前
已完结
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
5个月前
已完结
B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges
5个月前
已完结
Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: Results from a Phase Ib Study
5个月前
已完结
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study
5个月前
已完结
Treatment of primary Sjögren’s syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity
5个月前
已完结
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial
5个月前
已完结
皖公网安备34019202002308
